Abstract
Recent remarkable advancements in geometric deep generative models, coupled with accumulated structural data, enable structure-based drug design (SBDD) using only target protein information. However, existing models often struggle to balance multiple objectives, excelling only in specific tasks. BInD, a diffusion model with knowledge-based guidance, is introduced to address this limitation by co-generating molecules and their interactions with a target protein. This approach ensures balanced consideration of key objectives, including target-specific interactions, molecular properties, and local geometry. Comprehensive evaluations demonstrate that BInD achieves robust performance across all objectives, matching or surpassing state-of-the-art methods. Additionally, an NCI-driven molecule design and optimization method is proposed, enabling the enhancement of target binding and specificity by elaborating the adequate interaction patterns.